Supporting a Top-15 Biopharma Company with Brand Development Through Scenario Planning for CNS Agents
A top-15 biopharmaceutical company with an early-stage Central Nervous System (CNS) therapy had established two anticipated launch scenarios: accelerated and delayed timelines. They needed to create a brand plan that was built on a foundational understanding of the current disease area, market needs, and competitive landscape, while integrating alternative launch scenarios inclusive of regulatory hurdles to maximize preparedness. Learn how Lumanity helped.
Case Study
Oct 16, 2023
